The San Diego Blood Bank has appointed Crane Harris as the group's chief business officer. He is tasked with generating new partnerships and revenue streams to support the blood bank's mission of saving lives with high-quality blood services in partnership with the community, the group said. Harris previously served as director of business development at Illumina. Prior to Illumina, Harris held positions at La Jolla Pharmaceutical Company in both business development and overseeing the bioinformatics team. Harris has also held positions at Monsanto, the US Environmental Protection Agency, and Saatchi & Saatchi Advertising.
Lee Hartwell, Elliott Burkland
Lee Hartwell and Elliott Burkland have joined the board of directors of SEngine Precision Medicine. Hartwell is the former president and director of the Fred Hutch Cancer Research Center. He received the Nobel Prize in physiology or medicine in 2001. Burkland is an investor in SEngine.
Clinical Genomics has appointed Betsy Hanna as its chief commercial officer. Hanna previous served as president and chief operating officer at Origin. Prior to Origin, she held multiple positions over an eight-year period at Johnson & Johnson with her most recent position as VP of global strategic marketing for Vision Care.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.